Phibro Animal Health Co. (NASDAQ:PAHC) Shares Bought by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC grew its position in shares of Phibro Animal Health Co. (NASDAQ:PAHCGet Rating) by 406.0% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 70,303 shares of the company’s stock after purchasing an additional 56,410 shares during the period. Allspring Global Investments Holdings LLC owned approximately 0.17% of Phibro Animal Health worth $934,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Walleye Capital LLC lifted its stake in Phibro Animal Health by 86.5% during the second quarter. Walleye Capital LLC now owns 64,134 shares of the company’s stock worth $1,227,000 after purchasing an additional 29,749 shares in the last quarter. Seizert Capital Partners LLC raised its stake in shares of Phibro Animal Health by 55.6% in the second quarter. Seizert Capital Partners LLC now owns 29,677 shares of the company’s stock valued at $568,000 after acquiring an additional 10,607 shares in the last quarter. Cardinal Capital Management raised its stake in shares of Phibro Animal Health by 3.5% in the second quarter. Cardinal Capital Management now owns 47,529 shares of the company’s stock valued at $909,000 after acquiring an additional 1,593 shares in the last quarter. Gladius Capital Management LP acquired a new stake in shares of Phibro Animal Health in the second quarter valued at $68,000. Finally, Zebra Capital Management LLC raised its stake in shares of Phibro Animal Health by 14.2% in the second quarter. Zebra Capital Management LLC now owns 26,352 shares of the company’s stock valued at $504,000 after acquiring an additional 3,279 shares in the last quarter. 49.21% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the company. Morgan Stanley reduced their price objective on Phibro Animal Health from $21.00 to $20.00 and set an “equal weight” rating on the stock in a research note on Thursday, November 10th. StockNews.com lowered Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Friday, November 11th. Finally, Roth Capital initiated coverage on Phibro Animal Health in a report on Wednesday, December 21st. They issued a “buy” rating and a $18.00 target price on the stock. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, Phibro Animal Health currently has an average rating of “Hold” and an average price target of $18.33.

Phibro Animal Health Stock Performance

NASDAQ:PAHC opened at $15.33 on Friday. The firm has a market capitalization of $620.93 million, a PE ratio of 13.33, a price-to-earnings-growth ratio of 8.06 and a beta of 0.53. The business’s fifty day moving average price is $13.29 and its 200 day moving average price is $15.15. The company has a debt-to-equity ratio of 1.72, a current ratio of 3.30 and a quick ratio of 1.68. Phibro Animal Health Co. has a 12 month low of $11.75 and a 12 month high of $22.16.

Phibro Animal Health (NASDAQ:PAHCGet Rating) last issued its quarterly earnings data on Wednesday, November 9th. The company reported $0.21 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.26 by ($0.05). The firm had revenue of $232.50 million for the quarter, compared to analysts’ expectations of $224.19 million. Phibro Animal Health had a return on equity of 19.90% and a net margin of 4.85%. On average, sell-side analysts anticipate that Phibro Animal Health Co. will post 1.22 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, December 21st. Shareholders of record on Wednesday, November 30th were issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 3.13%. The ex-dividend date was Tuesday, November 29th. Phibro Animal Health’s payout ratio is 41.74%.

Phibro Animal Health Company Profile

(Get Rating)

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy cattle, aquaculture, and dogs.

Featured Articles

Institutional Ownership by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.